je.st
news
Breckenridge Announces Approval Of Rizatriptan Benzoate Tablets
2013-01-02 01:42:40| drugdiscoveryonline News Articles
Breckenridge Pharmaceutical, Inc.announced today the immediate launch of Rizatriptan Benzoate Tablets. The U.S. Food and Drug Administration granted finalapproval for the Abbreviated New Drug Application (ANDA) for this product, which is being manufactured and supplied by Natco Pharma Limited, and will be available in both 5mg and 10mg strengths
Tags: approval
announces
tablets
breckenridge
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||